SCHEMBL1279862

SCHEMBL1279862

CCCC(C)CC(C)C(C)CC

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7756805 0.80 TSHR (0.46) TSHR
SCHEMBL20610170 0.79 PTPN1 (0.32) TSHR
SCHEMBL17607403 0.79 TSHR (0.40) TSHR
SCHEMBL4269680 0.78 TSHR (0.56) TSHR
SCHEMBL20610204 0.78 TSHR (0.38) TSHR
SCHEMBL27272792 0.77 TSHR (0.39) TSHR
SCHEMBL25549095 0.77 TSHR (0.39) TSHR
SCHEMBL18850896 0.77 TSHR (0.39) TSHR
SCHEMBL27868962 0.77 TSHR (0.39) TSHR
SCHEMBL11177408 0.77 TSHR (0.44) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240140888-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER BIOSYNTHIS (FR) 2024-05-02 US claimed
CN-113912622-B Tricyclic pyrimidinone compounds, methods of making, compositions and uses thereof 上海纽思克生物科技有限公司 2023-12-01 CN claimed
CN-109384727-B Phthalazinone compound, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2023-07-28 CN claimed
CN-113861220-B Tricyclic pyrimidinone compounds, methods of making, compositions and uses thereof 上海纽思克生物科技有限公司 2023-06-16 CN claimed
CN-115745987-A Luciferase substrate and preparation method and application thereof 华东理工大学 2023-03-07 CN claimed
US-20260041617-A1 COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES BIOSYNTHIS (FR) 2026-02-12 US disclosed
US-20250197341-A1 METHOD FOR INHIBITING CRYSTALLISATION BIOSYNTHIS (FR) 2025-06-19 US disclosed
US-20250177263-A1 LIPSTICK COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES BIOSYNTHIS (FR) 2025-06-05 US disclosed
US-20250170037-A1 EYE MAKEUP COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES BIOSYNTHIS (FR) 2025-05-29 US disclosed
CN-119855583-A Composition for cosmetic treatment of keratin fibres 碧昂赛恩斯公司 2025-04-18 CN disclosed
EP-4496553-A1 COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES Biosynthis (FR) 2025-01-29 EP disclosed
EP-4486288-A1 EYE MAKEUP COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES Biosynthis (FR) 2025-01-08 EP disclosed
CN-116490535-A Method for producing polymer dispersions 巴斯夫欧洲公司 2023-07-25 CN disclosed
CN-113861220-B Tricyclic pyrimidinone compounds, methods of making, compositions and uses thereof 上海纽思克生物科技有限公司 2023-06-16 CN disclosed
EP-4056670-A1 METHOD FOR FRACTIONATING A SHEA EXTRACT Biosynthis (FR) 2022-09-14 EP disclosed
US-20200171214-A1 BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION DREI LILIEN PVG GMBH & CO. KG (DE) 2020-06-04 US disclosed
EP-3648806-A1 BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION Drei Lilien PVG GmbH & Co. KG (DE) 2020-05-13 EP disclosed
US-20120088911-A1 NOVEL CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND USE ABBOTT GMBH & CO. KG (DE) 2012-04-12 US disclosed
EP-0579071-A2 Heteroaromatic compounds and plant-protecting agents containing them BASF Aktiengesellschaft (DE) 1994-01-19 EP disclosed
US-5176739-A Plant growth regulators BASF AKTIENGESELLSCHAFT (DE) 1993-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240140888-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER ALKBH2, ABHD12, FAAH2 TSHR 3034/4885
US-20260041617-A1 COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES CUTA, AP2M1, LBR TSHR 612/4885
US-20120088911-A1 NOVEL CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND USE HCAR1, HCAR2, HCAR3 TSHR 922/4885
US-20250197341-A1 METHOD FOR INHIBITING CRYSTALLISATION FASN, SCD5, NFKB2 TSHR 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.